Oramed provides doses to patients across multiple sites
Oramed Pharmaceuticals Inc has announced that randomization of patients in its first Phase 3 study of its oral insulin capsule ORMD-0801 for the treatment...
AstraZeneca ties up with CCT to carry out Covid-19 vaccine trials in Arizona
CCT Research has announced forging a partnership with AstraZeneca to advance Covid-19 research.
By joining hands with with local healthcare providers, CCT, a leader in...
Postpartum depression may continue for 3 years after delivery
A new study has has found that approximately 1 in 4 experienced high levels of depressive symptoms at some point in the three years...
Covid immunity lasts for many months, says study of healthcare workers
In a relief to healthcare workers who put their lives under risk while treating those with Covid-19, new findings from a study of thousands...
Lilly’s tirzepatide brings down body weight in people with type 2 diabetes
Lilly's Tirzepatide led to superior A1C and body weight reductions from baseline in adults with type 2 diabetes.
This was achieved after 40 weeks of...
Codagenix, Serum Institute of India start first-in-human trial of Covid-19 vaccine
Codagenix, Inc., and the Serum Institute of India Pvt. Ltd. (SIIPL) have announced that a Phase 1 clinical trial of COVI-VAC received regulatory approval...
ResMed announces expansion of AirView remote monitoring for ventilation in India
ResMed has announced expansion of AirView for Ventilation, its cloud-based remote monitoring and management platform for respiratory care patients, in India.
According to the leading...
Moderna to supply additional 2 mn doses of Covid-19 vaccine to United Kingdom
Moderna, Inc. has announced a supply agreement with the United Kingdom government for an additional 2 million doses of mRNA-1273,
Moderna is a biotechnology company...
Lupus Research Awards 2023 announced
The Lupus Research Alliance (LRA) announced the recipients of the newest Lupus Innovation Award (LIA) grants.
Collectively, the seven projects led by research teams from the U.S. and Europe explore multiple...
Hydroxychloroquine doesn’t benefit adults hospitalised with Covid-19: NIH trial
A clinical trial by National Institutes of Health, evaluating the safety and effectiveness of hydroxychloroquine for the treatment of adults with Covid-19, has concluded...
